Zebra Technologies Guides Q2 Adj. EPS Below Estimates - Quick Facts

While reporting financial results for the first quarter on Tuesday, Zebra Technologies Corp. (ZBRA) provided its adjusted earnings and adjusted net sales growth guidance for the second quarter as well as maintains adjusted net sales growth outlook for the full year 2022.

For the second quarter, the company expects adjusted earnings in a range of $4.05 to $4.35 per share on adjusted net sales growth of 3 to 7 percent.

On average, analysts polled by Thomson Reuters expect the company to report earnings of $4.52 per share on net sales growth of 3.80 percent to $1.43 billion for the quarter. Analysts' estimates typically exclude special items.

Looking ahead to fiscal 2022, the company now still projects adjusted net sales growth of 3 to 7 percent. The Street is looking for sales growth of 5.60 percent to $5.95 billion for the year.

For the first quarter, net income declined to $205 million or $3.83 per share from $228 million or $4.22 per share in the prior-year quarter. Excluding items, adjusted net income for the quarter were $4.01 per share, compared to $4.79 per share in the year-ago quarter.

Net sales for the quarter grew 6.3 percent to $1.43 billion from $1.35 billion in the same quarter last year. Consolidated organic net sales increased 5.4 percent.

Analysts expected earnings of $3.87 per share on net sales of $1.37 billion for the quarter.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
United Airlines and Archer Aviation Inc. announced plans to launch the first commercial electric air taxi route in Chicago, between O'Hare International Airport or ORD and Vertiport Chicago. As part of their urban air mobility or UAM network buildout, both companies will utilize Archer's electric vertical takeoff and landing or eVTOL aircraft in the new route. Fort Wayne, Indiana-based Perfection Bakeries D/B/A Aunt Millie's is recalling 8 ct. packages of Our Family White Hot Dog Buns citing the possible presence of undeclared sesame, a known allergen, the U.S. Food and Drug Administration said. The product comes in a printed plastic package marked with "Our Family Hot Dog Buns 8 ct." on the top and has a blue twist tie. Parsippany, New Jersey -based Ascend Laboratories LLC. is recalling Dabigatran Etcxilate capsules citing the detection of N-Nitrosodimethylamine or NDMA impurity, a probable human carcinogen, the U.S. Food and Drug Administration said. The product is used as an oral anticoagulant to lower the risk of stroke and blood clots.
Follow RTT